Variants of the J774 mouse macrophage cell line that lack immunologically important membrane receptors were isolated. After mutagenesis, variants were selected in a metrizamide gradient that separated cells heavily rosetted with sheep erythrocytes (E) coated with rabbit anti-E IgG (EIgG) from poorly rosetted cells. Stable variants that exhibited altered binding were found with a frequency of <10-7, and five clones were studied in detail. The variants failed to bind E opsonized with a monoclonal mouse IgG2b anti-E antibody but bound monomeric IgG2a normally when compared to the parental J774 Mutagenesis. Cultures in exponential growth were mutagenized with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) (Aldrich) at a concentration of 1 ,g/ml in Hanks' solution for 1 hr or with ICR-170 (0.3 ,g/ml) for 16 hr in medium containing 10% fetal calf serum. The ICR-170 was kindly given to
IgG2a could inhibit the binding of soluble rabbit IgG-antigen complexes to the variants but not to the parent line. Finally, E coated with IgM and complement (EIgMC) were bound poorly by all the variants, relative to the J774 parent. These results show that rabbit IgG complexes are bound by both FcRI and FcRII on mouse macrophages. The impairment of EIgMC rosetting in the variants suggests that the C3b receptor and FcRII are related.
The role of macrophages in host defense is partially governed by the presence of immunological receptors on their plasma membrane. These receptors lead to the binding of both the C3b component of complement and the Fc domain of IgG and specify the phagocytosis of particles (1) or the extent of cellmediated cytotoxicity (2, 3) . Some controversy exists about the number and types of Fc receptors on mouse macrophages (4) (5) (6) (7) (8) (9) . Native macrophages and cell lines, however, display an Fc receptor (FcRII) that binds antigen-antibody complexes and aggregated mouse IgG2b and is resistant to trypsin (5-7) as well as a trypsin-sensitive FcRI receptor that binds monomeric IgG2a with high affinity (8) .
In order to characterize the Fc receptors further, we thought it would be useful to isolate variants with altered IgG binding. For this purpose the J774 cell line, which displays many of the characteristics of mouse peritoneal macrophages (10) 
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Binding Assays. Binding assays were performed on adherent cells in 16-mm wells (Linbro FB 16-24 TC) as described (5, 8) except that, after washing, the cells were removed from the dish by swabbing the wells with Q-tips, which were then assayed for radioactivity. Rabbit anti-DNP-IgG-DNPIo.9-albumin complexes were formed at a 5:1 (wt/wt) ratio which gave optimal cell binding. The binding of complexes or IgG2a to L cells was linear and these values were used to correct for nonspecific binding. Rabbit anti-DNP-F(ab')2-DNP1o.9-albumin complexes bound equally to L cells and cells of the J774 line.
EIgG and C3b-Coated EIgM(EIgMC)Binding. Cells grown overnight on 13-mm glass coverslips were incubated for 20 min at 370C with 1 ml of 0.5% EIgG or EIgMC suspended in H/G and then washed free of nonadherent cells by dipping in phosphate-buffered saline. In some experiments cells were trypsinized [1 mg of crystalline trypsin (Sigma) per ml, 15 min, 370CI prior to rosetting. The cells were fixed in 2.5% glutaraldehyde in phosphate-buffered saline, and at least 200 cells were scored for EIgG and EIgMC binding.
Latex Phagocytosis. Washed polyvinyltoluene latex particles (2.02 Jim; Dow Diagnostics) were suspended in 5% serum medium and 5 X 107 particles were added to cells for 1 hr at 370C.
Lysozyme Secretion. Lysozyme was assayed as described (15) (Fig. 1) Fig. 2 (Fig. 3) . At saturation, all the variants bound less than 20% of the amount bound by the J774 parent line (0.05 ,4g/3 X 105 cells). Because the binding of EIgG to some of the variants was trypsin-sensitive, and the FcRI that binds IgG2a was likewise trypsin-sensitive, we added IgG2a to the incubation mixtures to compete for the binding of the soluble rabbit immune complexes. The amount of IgG2a used (0.05 mg/ml) was about 30 times the Km for IgG2a at 4VC and largely inhibited the binding of complexes by the variants (Fig. 3) . Only slight inhibition occurred with the parent line and none with L cells which lack Fc receptors. These results suggest that soluble rabbit immune complexes bind to both trypsinsensitive and trypsin-resistant Fc receptors. Fig. 4 , demonstrating that these clones lack the trypsin-resistant receptor that binds IgG2b.
Binding of Monomeric IgG2a. The presence of the trypsin-sensitive FcRI on the variants was examined by using the monomeric mouse IgG2a myeloma protein LPC-1. Scatchard analysis of the binding data showed that the variant lines bound the mouse IgG2a myeloma protein with slightly higher affinity to a comparable number of sites ( (Figs. 1 and 2 ). This result was also unexpected because there was no obvious reason why a selection against EIgG-binding cells should select against EIgMC rosetting. Mouse peritoneal macrophages and the J774 cells phagocytose latex particles and secrete lysozyme. An unexpected result of these experiments was the decrease in binding of EIgMC by all the variants lacking FcRII. Because Fe receptors and C3b receptors appear at different times during macrophage maturation (17) , and also differ in trypsin sensitivity (18), these two receptors are probably not the same. They might, however, share common polypeptides or be affected by a common processing, insertion, or glycosylation defect. Glycosylation defects that block insertion of the Thy-I protein and also affect glycosylation of other cell surface components have been reported by Trowbridge et al. (19) . In a study of the abnormal glycosylation of immunoglobulin heavy chain in a myeloma mutant, Weitzman et al. (20) found abnormal glycosylation of the H-2D but not the H-2K product of the mouse major histocompatibility locus. Because the morphologic and adherence properties of the variants were so different from those of J774, the defect(s) may involve general membrane processing steps.
Muschel et al. (21) devised a "Trojan horse" selection scheme in which EIgG loaded with the toxic drug tubercidin were fed to J774 cells to isolate variants deficient in phagocytosis of EIgG. These variants were isolated at a frequency of 1 per 1.7 X 104 MNNG mutagenized cells, a much higher frequency than that reported here for FcRII variants. Although the "Trojan horse" selection could produce variants that were not killed because of lack of EIgG binding, such variants were not found, which may reflect the difficulty of isolating variants present at a very low frequency in a much larger population of poorly phagocytic cells.
There have been several reports on the isolation of macrophage Fc receptors, but there is a lack of general agreement on their structure. Loube et al. (22) reported three polypeptides of Mr 57,000, 28,000, and 24,000; Bourgois et al. (23) reported a peptide of Mr 120,000 present on macrophages, lymphocytes, and fibroblasts; and Cunningham-Rundles et al. (24) reported a peptide of Mr 60,000 from human mononuclear cells. FcRII variant clones described here will be useful for the investigation of the function of the Fc and complement receptors and in providing favorable material for the isolation of the FcRI that binds IgG2a.
